Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX EPS (Diluted)

Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.

No reported EPS (Diluted) figures are available to summarize.

EPS (Diluted) history

Currency unavailable · from the income statement

No EPS (Diluted) data reported for this period type.

EPS (Diluted) vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
EPS (Diluted) for ODTX and competitors
Company Period LTM YoY 3-year CAGR
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$1.03 USD+47.7%—
ACRSAclaris Therapeutics, Inc.LTM Mar 2026-$0.56 USD+59.7%—
ANABAnaptysBio, Inc.LTM Mar 2026-$1.08 USD+78.0%—
AGMBAgomAb Therapeutics N.V. American Depositary SharesFY2024-€1.26 EUR-306.5%—
ORKAOruka Therapeutics, Inc.LTM Sep 2026-$2.41 USD+27.2%—
SYRESpyre Therapeutics, Inc.LTM Sep 2026-$2.74 USD-166.0%—
ALMSAlumis Inc. Common StockLTM Jun 2026-$3.8 USD+15.9%—
IMUXImmunic, Inc.LTM Mar 2026-$5.98 USD+39.0%—
ODTXOdyssey Therapeutics, Inc.—— ——
Peer median (excluding ODTX) —+33.1%—

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.